Director, Serology Assay Innovation Hub

The Assay Innovation Hub Director will lead the development and implementation of innovative testing platforms and methodologies in clinical serology, immunology, and early clinical research evaluation. The Assay Discovery Hub in ADI is envisioned as a centralized, innovative platform dedicated to advancing serological capabilities for various priority vaccine programs for GSK VIDRU organization., Leadership:

• Lead a team of scientists define assay strategies, develop and validate new testing platforms, and deliver results aligned with company objectives.

• Foster innovation in clinical serology and early clinical research to address emerging challenges in vaccine development.

• Partner with other platform heads within ADI in early evaluation of new serological methods and other platforms in Vx CLAP

Scientific and Technical Expertise:

• Develop, maintain, and improve a portfolio of assays to assess vaccine immunogenicity and efficacy.

• Implement state-of-the-art methodologies through constant scientific and technological surveillance.

• Collaborate with internal and external stakeholders, including academic institutions and key opinion leaders, to share expertise and drive innovation.

Regulatory and Clinical Contributions:

• Develop documents for regulatory submissions and address inquiries from regulatory authorities.

• Contribute to internal and external publications and communications related to assay innovation.

Resource Planning and Management:

• Prioritize activities to achieve key milestones within agreed timelines and budgets.

• Manage resources effectively, including OpEx and CapEx planning, and oversee outsourced activities related to assay development and testing.

• PhD in Immunology, microbiology, bioassay, vaccinology

• 8+ years of experience in assay development for clinical serology/immunology in the context of vaccine development

• 4+ years line management experience and previous experience leading teams of 5+ scientists

• Track record of automation adoption and new technology assessment, including computational or AI tools

• Experience in regulated laboratory environments and GxP

• Good understanding of new product clinical development organization and procedures

Preferred Qualifications

• Post-doctoral research in Immunology, microbiology, bioassay, vaccinology

• Deep expertise in Cell based Functional immunoassays - viral neutralization, bacterial opsonophagocytic killing; Flow cytometric analysis; Ligand binding assays; high-throughput omics assay.

• If you are based in Cambridge, MA; Waltham, MA; Rockville, MD; or San Francisco, CA, the annual base salary for new hires in this position ranges $178,200 to $297,000.

The US salary ranges take into account a number of factors including work location within the US market, the candidate’s skills, experience, education level and the market rate for the role. In addition, this position offers an annual bonus and eligibility to participate in our share based long term incentive program which is dependent on the level of the role. Available benefits include health care and other insurance benefits (for employee and family), retirement benefits, paid holidays, vacation, and paid caregiver/parental and medical leave.

Uniting science, technology and talent to get ahead of disease together.

GSK is a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive. We get ahead of disease by preventing and treating it with innovation in specialty medicines and vaccines. We focus on four therapeutic areas: respiratory, immunology and inflammation; oncology; HIV; and infectious diseases - to impact health at scale.

People and patients around the world count on the medicines and vaccines we make, so we’re committed to creating an environment where our people can thrive and focus on what matters most. Our culture of being ambitious for patients, accountable for impact and doing the right thing is the foundation for how, together, we deliver for patients, shareholders and our people.